WAR · Healthcare
Biotechnology
Nanogroup SA (NNG) is listed on WAR in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
The price-to-earnings (P/E) ratio for Nanogroup SA (NNG) is 25.00 (data as of 2026-05-24).
Dividend yield is not available in the current snapshot for Nanogroup SA (NNG). Check the MyAverix Finance app for the latest dividend data.
Nanogroup SA (NNG) is classified in the Healthcare sector (Biotechnology industry).
NNG is listed on WAR.
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.